Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel Á. Sanz, Francesco Lo‐Coco, Sai-Juan Chen et al.|Blood|2019Cited by 655
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed MyelomaBrian A. Walker, Gareth J. Morgan, Eileen M. Boyle et al.|Journal of Clinical Oncology|2015Cited by 564
Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 TrialAlan K. Burnett, Donald Milligan, Nigel H. Russell et al.|Journal of Clinical Oncology|2013Cited by 415
Pretransplant <i>FLT3</i>-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcomeSun Loo, Andrew H. Wei, Richard Dillon et al.|Blood|2022Cited by 83
Molecular, clinical, and therapeutic determinants of outcome in <i>NPM1</i>-mutated AMLJad Othman, Richard Dillon, Nicola Potter et al.|Blood|2024Cited by 78